Company Performance Metrics
- Perry Brunette: CEO, CFO, Vice-President
PathFree Technologies Corporation is a prominent medical device manufacturer based in Irvine, California, deeply committed to leveraging American ingenuity and manufacturing. The company prides itself on its dedication to producing innovative, high-quality products that cater to the modern healthcare sector. Under the leadership of President Lianna
Zhang and CEO Perry M. Brunette, PathFree Technologies has made significant strides in the medical device industry, focusing on AI-driven emergency medical solutions.
Lianna Zhang, Co-founder with a rich background in health and wellness, brings over 20 years of successful entrepreneurship to her role at PathFree. Her journey from Beijing to the United States has been marked by resilience and a commitment to community involvement, making her a role model in the entrepreneurial space.
Dr. Perry Brunette Ph.D., Co-founder and CEO - Known for his financial acumen and technological insight, particularly in the medical device sector. His leadership has been pivotal in steering PathFree towards innovation and significant growth. Brunette's approach to blending finance with technology, especially evident in projects like the AiCart, underscores the company's commitment to advancing healthcare through innovation.
Neil Sahota, CCO - Commercialization strategist with experience. United Nations Advisor, IBM Master Inventor, and Tech Coast Angel. Specialist guiding Fortune 500 companies, government agencies, non-profits, and academic institutions in leadership for the digital future.
Dr. Lia DiBello, CSO - Ph.D. in Cognitive Science with over 30 years of experience in the field. Specializing in the application of intuitive expertise in complex and dynamic situations, and how technology can support and accelerate this process.
Darren Saravis, CTO - Seasoned innovator and entrepreneur, known for transforming visionary medical concepts into commercially successful products, bridging the gap between design, engineering, and market strategy.
Elaine Duncan, Regulatory Expert - Leading expert in regulatory and clinical strategies for medical technology, with extensive experience in both Fortune 500 companies and start-ups. She specializes in guiding clients through regulatory pathways, biocompatibility analysis, and product validation for global markets.
Sally Dillehay, Regulatory Submissions Expert - Extensive experience in FDA/CE/ISO regulatory submissions, quality systems, and clinical trials for medical devices and pharmaceuticals. Skilled in developing clinical literature reviews, evaluation reports, and data transition plans for MEDDEV and MDR submissions.
Kerry Ann Eiss, Clinical Expert - RN, BSN, CLNC with over two decades of experience in healthcare innovation, including expertise in cardiovascular and cardiothoracic operating rooms, emergency medicine, geriatrics, pediatric psychiatry, and general surgery.
Daniel Miller MD, Medical Director- eICU and Telehealth Center Critical Care Physician - Board-certified physician specializing in clinical research, internal medicine, and critical care medicine, with extensive experience in healthcare management and medical education. Highly endorsed by colleagues at Staten Island University Hospital, they are recognized for their expertise in critical care, ACLS, and hospital operations.
Andrey V Tytchino Ph.D., Computer Science Research Officer - Extensive experience in Artificial Intelligence, Machine Learning, data analysis, and Analytical Chemistry research. Experienced professional in IT Security, Penetration Testing, Security Testing, and Enterprise Security Policy Enforcement. Results-oriented individual with strong data and log analysis skills to detect suspicious activities, security breaches, data theft attempts, and privacy non-compliance using all available IT resources.
Jeenchen (Robert) Chen MD, MPH, EA, ChFC®, CLU®, RICP®; Cardiovascular Surgeon - With over two decades of experience in cardiothoracic surgery. A role that facilitates critical breakthroughs, ensuring that the next generation of medical professionals is equipped to push the boundaries of what's possible in cardiovascular medicine.
Brad Schwartz MD, Healthcare Innovation Leader AI, Medical Contact Centers, EMS Advisory - Board-certified and Residency Trained professional in Internal Medicine and Emergency Medicine. spearheading initiatives in Medical Contact Centers, Nurse Advice, Triage, Virtual Medicine, and Protocol development. Serving as the Medical Director for an Ambulance Company, I bring hands-on experience in navigating the complexities of healthcare.
Denise Chamberlain MAEd, CPA, LFACHE Senior Executive Healthcare Finance Leader - A seasoned financial and healthcare executive with expertise in strategic leadership, fiscal management, and organizational transformation. With a strong background in corporate finance and healthcare administration, she has successfully led large-scale financial initiatives and operational improvements. Known for her visionary approach and commitment to excellence, Denise continues to drive sustainable growth and innovation in the industry.
Mark Maydew, Private practice, Healthcare executive - Nearly 20 years, serving in clinical, practice management. With a diverse skill-set, including clinical experience, data analysis, leadership, and experience building healthcare companies. Mark gained experience working directly with providers, support staff, and executives. Responsible for financial and operational oversight of a rapidly growing, independent, medical practice with 13 Urgent & Primary Care locations and 400 employees.
Richard L Trader, MMsc PA-C FCCM, Director of the Institute of Health Sciences - Former Director of Critical Care Services / Sinai Hospital of Baltimore - Instructor Department of Medicine Sinai/John Hopkins University - Registered Physician Associate with Specialty Certification in Primary Care and SurgeryRegistered Respiratory Therapist- Fellow - American College Of Critical Care Medicine. Developed Digital Technology for Cardiovascular Medicine through FDA. Developed and acquired Manufacturing Development (through FDA) for remote transmission of cardiac data : remote monitoring of ventilators: and dual lung ventilation.
PathFree Technologies has recently grabbed headlines for its astonishing valuation leap from $112 million to over $1 billion within just seven months, thanks to its flagship device, the AiCart, and the anticipation of additional groundbreaking medical devices. This valuation reflects the potential of PathFree's technology to transform emergency medical care.
PathFree's unwavering commitment to American manufacturing is a cornerstone of its identity. The company ensures that all its manufacturing processes are kept within the United States to maintain the highest quality standards and support the American economy. By sourcing raw materials and components from American suppliers, PathFree not only champions the Made in America ethos but also contributes to job creation and economic growth domestically.
In conclusion, PathFree Technologies Corporation represents a blend of visionary leadership, technological innovation, and a strong commitment to American manufacturing and quality. Its focus on AI-driven solutions in the medical device industry positions it as a forward-thinking company with a bright future in enhancing healthcare standards globally.